Carisma Therapeutics(CARM)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CARM Carisma Therapeutics

交易中 04-23 11:59:39 EDT

0.2082

-0.0037

-1.75%

最高0.2296	最低0.2082	成交量7.05万
今开0.2110	昨收0.2119	日振幅10.10%
总市值870.03万	流通市值630.02万	总股本4,179万
成交额1.54万	换手率0.23%	流通股本3,026万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CARM","market":"US","secType":"STK","nameCN":"Carisma Therapeutics","latestPrice":0.2082,"timestamp":1745423624166,"preClose":0.2119,"halted":0,"volume":70522,"delay":0,"floatShares":30260519,"shares":41788096,"eps":-1.458816,"marketStatus":"交易中","change":-0.0037,"latestTime":"04-23 11:59:39 EDT","open":0.211,"high":0.2296,"low":0.2082,"amount":15427.656472280001,"amplitude":0.100991,"askPrice":0.2149,"askSize":500,"bidPrice":0.2115,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.458816,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1745438400000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":0.2119,"preHourTrading":{"tag":"盘前","latestPrice":0.2095,"preClose":0.2119,"latestTime":"08:58 EDT","volume":10,"amount":2.0949999999999998,"timestamp":1745413090919},"postHourTrading":{"tag":"盘后","latestPrice":0.193,"preClose":0.2119,"latestTime":"19:31 EDT","volume":4555,"amount":887.5799,"timestamp":1745364702133},"volumeRatio":1.210857},"requestUrl":"/m/hq/s/CARM","defaultTab":"news","newsList":[{"id":"2529553362","title":"Carisma Therapeutics, Inc.盘中异动 大幅拉升5.02%报0.199美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529553362","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529553362?lang=zh_cn&edition=full","pubTime":"2025-04-23 02:21","pubTimestamp":1745346095,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日02时21分，Carisma Therapeutics, Inc.股票出现波动，股价大幅拉升5.02%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.87%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042302213694de72d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042302213694de72d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CARM","LENZ","BK4007"],"gpt_icon":0},{"id":"2528674333","title":"Carisma Therapeutics, Inc.盘中异动 股价大跌5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528674333","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528674333?lang=zh_cn&edition=full","pubTime":"2025-04-17 21:40","pubTimestamp":1744897247,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日21时40分，Carisma Therapeutics, Inc.股票出现波动，股价快速跳水5.43%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417214047973b53e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417214047973b53e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CARM","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2527146337","title":"Carisma Therapeutics, Inc.盘中异动 大幅上涨5.51%报0.218美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527146337","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527146337?lang=zh_cn&edition=full","pubTime":"2025-04-15 03:49","pubTimestamp":1744660189,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日03时49分，Carisma Therapeutics, Inc.股票出现异动，股价大幅拉升5.51%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.81%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415034950aa2c6f22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415034950aa2c6f22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CARM","BK4007","BK4139"],"gpt_icon":0},{"id":"2518273788","title":"Carisma Therapeutics, Inc.盘中异动 早盘股价大跌6.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518273788","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518273788?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:33","pubTimestamp":1741613632,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时33分，Carisma Therapeutics, Inc.股票出现异动，股价大幅下跌6.29%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213352a26a2585&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213352a26a2585&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CARM","BK4139","LENZ"],"gpt_icon":0},{"id":"2517161899","title":"Carisma Therapeutics, Inc.盘中异动 早盘股价大涨5.00%报0.420美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517161899","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517161899?lang=zh_cn&edition=full","pubTime":"2025-03-06 23:10","pubTimestamp":1741273800,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日23时10分，Carisma Therapeutics, Inc.股票出现波动，股价大幅拉升5.00%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306231000a2629aa1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306231000a2629aa1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CARM"],"gpt_icon":0},{"id":"2514885637","title":"Carisma Therapeutics, Inc.盘中异动 早盘急速拉升6.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514885637","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514885637?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:34","pubTimestamp":1740580499,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时34分，Carisma Therapeutics, Inc.股票出现异动，股价大幅上涨6.93%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223459abddedd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223459abddedd5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CARM"],"gpt_icon":0},{"id":"2514016841","title":"Carisma Therapeutics, Inc.盘中异动 急速跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514016841","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514016841?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:31","pubTimestamp":1740497479,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时31分，Carisma Therapeutics, Inc.股票出现波动，股价急速跳水5.00%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.76%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225233119a2539568&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225233119a2539568&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CARM"],"gpt_icon":0},{"id":"2512694181","title":"Carisma Therapeutics, Inc.盘中异动 股价大跌8.43%报0.451美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512694181","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512694181?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:12","pubTimestamp":1739891530,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日23时12分，Carisma Therapeutics, Inc.股票出现波动，股价快速跳水8.43%。截至发稿，该股报0.451美元/股，成交量3.4266万股，换手率0.08%，振幅6.26%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.80%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218231211abd3b86f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218231211abd3b86f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CARM"],"gpt_icon":0},{"id":"2511669690","title":"Carisma Therapeutics, Inc.盘中异动 大幅下跌5.84%报0.447美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511669690","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511669690?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:43","pubTimestamp":1739544208,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时43分，Carisma Therapeutics, Inc.股票出现异动，股价大幅跳水5.84%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422432898858ca5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422432898858ca5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CARM"],"gpt_icon":0},{"id":"2510866329","title":"Carisma Therapeutics, Inc.盘中异动 股价大跌5.08%报0.439美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510866329","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510866329?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:42","pubTimestamp":1739198560,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时42分，Carisma Therapeutics, Inc.股票出现异动，股价急速下跌5.08%。截至发稿，该股报0.439美元/股，成交量1.789万股，换手率0.04%，振幅1.08%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210224240a240a4d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210224240a240a4d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CARM"],"gpt_icon":0},{"id":"2509744626","title":"Carisma Therapeutics, Inc.盘中异动 股价大涨8.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509744626","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509744626?lang=zh_cn&edition=full","pubTime":"2025-02-07 22:31","pubTimestamp":1738938684,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日22时31分，Carisma Therapeutics, Inc.股票出现波动，股价快速拉升8.00%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207223124961b38e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207223124961b38e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CARM","LENZ"],"gpt_icon":0},{"id":"2509238246","title":"Carisma Therapeutics, Inc.盘中异动 早盘快速拉升6.72%报0.495美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509238246","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509238246?lang=zh_cn&edition=full","pubTime":"2025-02-05 23:26","pubTimestamp":1738769210,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日23时26分，Carisma Therapeutics, Inc.股票出现异动，股价快速拉升6.72%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.27%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205232650987b861b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205232650987b861b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CARM","LENZ","BK4139"],"gpt_icon":0},{"id":"2508141736","title":"Carisma Therapeutics, Inc.盘中异动 大幅跳水6.26%报0.431美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508141736","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508141736?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:32","pubTimestamp":1738593131,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时32分，Carisma Therapeutics, Inc.股票出现波动，股价大幅下挫6.26%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.51%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223211abc106dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223211abc106dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CARM"],"gpt_icon":0},{"id":"2507965724","title":"Carisma Therapeutics, Inc.盘中异动 早盘股价大跌6.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507965724","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507965724?lang=zh_cn&edition=full","pubTime":"2025-01-31 22:31","pubTimestamp":1738333917,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日22时31分，Carisma Therapeutics, Inc.股票出现异动，股价急速下挫6.25%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.62%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131223157abbe3ba8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131223157abbe3ba8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CARM"],"gpt_icon":0},{"id":"2507811621","title":"Carisma Therapeutics, Inc.盘中异动 大幅下跌6.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507811621","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507811621?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:32","pubTimestamp":1738247535,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时32分，Carisma Therapeutics, Inc.股票出现异动，股价大幅下挫6.80%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223216abbd4c67&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223216abbd4c67&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CARM","BK4139"],"gpt_icon":0},{"id":"2506005543","title":"Carisma Therapeutics, Inc.盘中异动 急速拉升5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506005543","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506005543?lang=zh_cn&edition=full","pubTime":"2025-01-28 01:11","pubTimestamp":1737997885,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日01时11分，Carisma Therapeutics, Inc.股票出现异动，股价大幅拉升5.04%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501280111259874c8af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501280111259874c8af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CARM","BK4139"],"gpt_icon":0},{"id":"2506818028","title":"Carisma Therapeutics, Inc.盘中异动 急速上涨5.50%报0.466美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506818028","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506818028?lang=zh_cn&edition=full","pubTime":"2025-01-25 04:28","pubTimestamp":1737750497,"startTime":"0","endTime":"0","summary":"北京时间2025年01月25日04时28分，Carisma Therapeutics, Inc.股票出现异动，股价快速拉升5.50%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.70%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125042817abb79989&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125042817abb79989&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CARM"],"gpt_icon":0},{"id":"2503864913","title":"Carisma Therapeutics, Inc.盘中异动 早盘股价大跌5.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503864913","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503864913?lang=zh_cn&edition=full","pubTime":"2025-01-16 22:31","pubTimestamp":1737037897,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日22时31分，Carisma Therapeutics, Inc.股票出现异动，股价急速下挫5.72%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116223138a2245f81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116223138a2245f81&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CARM","BK4139","LENZ"],"gpt_icon":0},{"id":"2502286758","title":"Carisma Therapeutics, Inc.盘中异动 早盘大幅下挫5.08%报0.450美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502286758","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502286758?lang=zh_cn&edition=full","pubTime":"2025-01-10 22:40","pubTimestamp":1736520006,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日22时40分，Carisma Therapeutics, Inc.股票出现异动，股价快速跳水5.08%。Carisma Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.53%。Carisma Therapeutics, Inc.公司简介：CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501102240069861ea45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501102240069861ea45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CARM"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sesenbio.com","stockEarnings":[{"period":"1week","weight":0.0756},{"period":"1month","weight":-0.4878},{"period":"3month","weight":-0.5186},{"period":"6month","weight":-0.7876},{"period":"1year","weight":-0.8867},{"period":"ytd","weight":-0.494}],"compareEarnings":[{"period":"1week","weight":-0.0193},{"period":"1month","weight":-0.0651},{"period":"3month","weight":-0.1306},{"period":"6month","weight":-0.0898},{"period":"1year","weight":0.0551},{"period":"ytd","weight":-0.1004}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"CARISMA Therapeutics Inc.于2008年2月25日在特拉华州法律下成立。该公司是一家临床阶段细胞治疗公司，专注于利用专有的CAR-M细胞治疗平台开发用于治疗癌症和严重疾病的转化免疫疗法。该公司创建了一个全面的细胞治疗平台，使工程化巨噬细胞和单核细胞的治疗用途成为可能，属于白细胞的一个亚群，称为髓细胞。","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":-0.098435},{"month":2,"riseRate":0.272727,"avgChangeRate":0.024429},{"month":3,"riseRate":0.416667,"avgChangeRate":-0.101631},{"month":4,"riseRate":0.5,"avgChangeRate":0.255274},{"month":5,"riseRate":0.545455,"avgChangeRate":0.110205},{"month":6,"riseRate":0.727273,"avgChangeRate":0.139785},{"month":7,"riseRate":0.181818,"avgChangeRate":0.036568},{"month":8,"riseRate":0.454545,"avgChangeRate":-0.01952},{"month":9,"riseRate":0.363636,"avgChangeRate":-0.081936},{"month":10,"riseRate":0.363636,"avgChangeRate":-0.064229},{"month":11,"riseRate":0.454545,"avgChangeRate":0.010922},{"month":12,"riseRate":0.454545,"avgChangeRate":-0.050206}],"exchange":"NASDAQ","name":"Carisma Therapeutics","nameEN":"Carisma Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Carisma Therapeutics(CARM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Carisma Therapeutics(CARM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Carisma Therapeutics,CARM,Carisma Therapeutics股票,Carisma Therapeutics股票老虎,Carisma Therapeutics股票老虎国际,Carisma Therapeutics行情,Carisma Therapeutics股票行情,Carisma Therapeutics股价,Carisma Therapeutics股市,Carisma Therapeutics股票价格,Carisma Therapeutics股票交易,Carisma Therapeutics股票购买,Carisma Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Carisma Therapeutics(CARM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Carisma Therapeutics(CARM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}